176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.33%
Some net income increase while MRVL is negative at -249.87%. John Neff would see a short-term edge over the struggling competitor.
10.39%
Some D&A expansion while MRVL is negative at -2.98%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
64.51%
Some yoy growth while MRVL is negative at -32.69%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
8.59%
SBC growth well above MRVL's 2.26%. Michael Burry would flag major dilution risk vs. competitor’s approach.
149.76%
Slight usage while MRVL is negative at -100.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-101.53%
AR is negative yoy while MRVL is 134.90%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-21.67%
Both reduce yoy inventory, with MRVL at -1276.09%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
105.22%
A yoy AP increase while MRVL is negative at -19.44%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
4124.14%
Some yoy usage while MRVL is negative at -100.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-975.44%
Negative yoy while MRVL is 5796.12%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
21.67%
Operating cash flow growth below 50% of MRVL's 75.03%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
16.79%
Some CapEx rise while MRVL is negative at -40.45%. John Neff would see competitor possibly building capacity while we hold back expansions.
46.76%
Less M&A spending yoy vs. MRVL's 100.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
0.89%
Purchases growth of 0.89% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-58.34%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
302.72%
We have some outflow growth while MRVL is negative at -104.63%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-36.49%
Both yoy lines negative, with MRVL at -42.45%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-53.63%
Both yoy lines negative, with MRVL at -14.29%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.